Japan· JP-6415002X1014
キニーネ塩酸塩水和物
A quinine product containing キニーネ塩酸塩水和物, registered in Japan, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Quinine is registered in 9 of 19 countries.
Countries holding a registration under ATC P01BC01 (quinine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Quinine · ATC P01BC01
9 / 19 countries
- Canada
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- キニーネ塩酸塩水和物
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- P01BC01
- ATC class
- Quinine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
496 interactions on record for quinine.
Graded by severity as the source publishes them — 102 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinine · interactions on record
496 records
- 102 severe
- 378 moderate
- 16 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Sodium picosulfateA06AB08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quinine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomQuinine bisulfate 100mg/5ml oral solutionSpecial Order
- United StatesChininum sulphuricumBoiron
- CanadaPRO-QUININE - 200PRO DOC LIMITEE
- GermanyChinin AxunioAxunio Pharma Gmbh
- FranceQUININE RENAUDIN 245 mg/ml, solution injectable pour perfusion IVLABORATOIRE RENAUDIN
- IrelandQuinine Sulphate 300 mg film coated tabletsTeva B.V.
- NetherlandsA-QS 200 Kininesulfaat-dihydraat 200 mg, filmomhulde tablettenACE Pharmaceuticals B.V.
- NorwayKinin NAFKragerø Tablettproduksjon AS
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Cyprus · Quinine Sulphate Remedica
- Germany · Chinin Axunio, Chinin Divapharma
- Denmark · Chininsulfate Axunio
- France · Quinine Renaudin
- United Kingdom (Northern Ireland) · Quinine Bisulfate, Quinine Bisulfate Strides Pharma Uk
- Ireland · Quinine Sulphate Teva
- Italy · Chinina Cloridrato Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico Militare, Chinina Cloridrato Galenica Senese
- Netherlands · A-Qs 200
- Portugal · Quinina Labesfal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d572286e-1319-4772-a2d2-22fcff2f4caf GET /v1/drugs/d572286e-1319-4772-a2d2-22fcff2f4caf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "1g",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6415002X1014",
"category": "内用薬",
"price_yen": null,
"generic_name": "キニーネ塩酸塩水和物",
"product_name_jp": null,
"therapeutic_class": "6415",
"transitional_expiry": null
}See everything about quinine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.